US Patent Reform Would Raise Drug Costs

 
• By Aidan Fry
  
Infringement
Proposed patent-reform legislation in the US would raise drug costs by undermining inter partes reviews that are used to invalidate weak patents • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin